First Implantation Of SPIRA®-O Open Matrix OLIF

Section 2

Northwell Health Sends Vaccinators to Ecuador

At the request of Ecuador’s Minster of Health, and for the first time since the start of the pandemic, the Northwell Health CGH team traveled outside of the U.S. on June 13 to help get shots in arms relieve overburdened health care workers in the South American country who have been working around the clock in the race to vaccinate their population.

Fusion Marketplace Changes Healthcare Traveler Experience

Fusion Marketplace is a traveler-first driven platform giving healthcare professionals the power to make decisions in their careers that they haven't been able to in the past.

Camber Spine, a leading innovator in spine and medical technologies, today announced the implantation of their first oblique lumbar interbody fusion (OLIF) specific device from the SPIRA® family using the company’s proprietary SPIRA®-O Open Matrix OLIF, a unique, interbody fusion implant consisting of spiral support arches and Surface by Design™ technology.

Dr. Jeffrey McConnell, MD of Allentown, PA was the first surgeon to clinically implant the SPIRA®-O device into a patient: “I have been a long-time supporter of the SPIRA® technology from Camber Spine, like other SPIRA® products this is a solid performer in terms of strength, ease of insertion, and I appreciate the surface texturing which encourages fusion between the bone and the implant.  I see faster and more robust fusions in all my patients.  Now that Camber has developed an implant that is specific to the anterior to psoas approach, I am able to access all levels of the lumbar spine from one patient position, and the SPIRA®-O instrumentation and design has enabled me with the ability to place deformity corrective sized implants in each level without the complications associated with utilizing risky orthogonal moves. This product is a great addition to the SPIRA® line and makes OLIF’s easier”.

The SPIRA®-O is a deliberately designed implant with a straight in-line insertion taking advantage of a natural corridor for an oblique, anterior to psoas, approach while the patient is in a lateral position.  The SPIRA®-O is specifically designed with implant configurations, lordotic angles and associated instruments to access all levels of the lumbar spine without an orthogonal maneuver.  The SPIRA®-O also incorporates Camber Spine’s proprietary technology Surface by Design® and its patented arch design for redistribution of load and decreased subsidence while maximizing bone graft volume.

Daniel Pontecorvo, CEO of Camber Spine, stated “The SPIRA®-O is a monumental leap forward in Camber’s single position platform.  By incorporating our patented and proven open architecture design with surgeon innovations in access and approach to the lumbar spine, Camber has figured out how to address complex spine pathologies from one approach angle where others have failed to innovate.  This area of the spine calls for specific implants and instruments to be created to give the surgeon the best results, Camber has now created a device specific for the OLIF approach while most other companies continue to repurpose their existing lateral platforms, without success. SPIRA®-O and our upcoming training labs will transform the way surgeons are treating lumbar deformity.”

The SPIRA®-O device is being evaluated by the surgeon design team for the next 90 days with an expected full nationwide launch during late September.



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles